OrbiMed’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-95,100
| Closed | -$548K | – | 113 |
|
|
2025
Q1 | $548K | Hold |
95,100
| – | – | 0.01% | 106 |
|
|
2024
Q4 | $880K | Hold |
95,100
| – | – | 0.02% | 112 |
|
|
2024
Q3 | $1.56M | Hold |
95,100
| – | – | 0.03% | 113 |
|
|
2024
Q2 | $1.81M | Hold |
95,100
| – | – | 0.04% | 106 |
|
|
2024
Q1 | $2.54M | Sell |
95,100
-130,818
| -58% | -$2.25M | 0.05% | 102 |
|
|
2023
Q4 | $3.09M | Hold |
225,918
| – | – | 0.06% | 93 |
|
|
2023
Q3 | $3.5M | Hold |
225,918
| – | – | 0.08% | 106 |
|
|
2023
Q2 | $4.88M | Hold |
225,918
| – | – | 0.09% | 103 |
|
|
2023
Q1 | $4.01M | Hold |
225,918
| – | – | 0.08% | 107 |
|
|
2022
Q4 | $3.82M | Hold |
225,918
| – | – | 0.07% | 97 |
|
|
2022
Q3 | $7.46K | Hold |
225,918
| – | – | 0.14% | 95 |
|
|
2022
Q2 | $12.7K | Hold |
225,918
| – | – | 0.23% | 80 |
|
|
2022
Q1 | $13.2M | Hold |
225,918
| – | – | 0.21% | 89 |
|
|
2021
Q4 | $16.3M | Hold |
225,918
| – | – | 0.21% | 96 |
|
|
2021
Q3 | $18.3M | Hold |
225,918
| – | – | 0.2% | 101 |
|
|
2021
Q2 | $21.8M | Hold |
225,918
| – | – | 0.22% | 94 |
|
|
2021
Q1 | $27.1M | Hold |
225,918
| – | – | 0.25% | 85 |
|
|
2020
Q4 | $29.6M | Hold |
225,918
| – | – | 0.26% | 84 |
|
|
2020
Q3 | $23.9M | Hold |
225,918
| – | – | 0.3% | 80 |
|
|
2020
Q2 | $58.1M | Hold |
225,918
| – | – | 0.82% | 36 |
|
|
2020
Q1 | $100M | Hold |
225,918
| – | – | 1.7% | 19 |
|
|
2019
Q4 | $153M | Hold |
225,918
| – | – | 2.19% | 14 |
|
|
2019
Q3 | $83.6M | Hold |
225,918
| – | – | 1.6% | 20 |
|
|
2019
Q2 | $40.6M | Buy |
+225,918
| New | +$47M | 0.64% | 46 |
|
Other funds holding NXTC
SI
AAA
P
CCC
CPA